CIRM CEO Mills On California's Last $800m For Stem Cells

Randal Mills left Osiris Therapeutics a few years after the company won the first-ever approval for a stem cell therapy and wasn't sure where he'd go next, but Mills ended up moving across the country to help California's stem cell research funding agency decide how best to spend its last $800m.